tiprankstipranks
VYNE Therapeutics (VYNE)
NASDAQ:VYNE
US Market

VYNE Therapeutics (VYNE) Stock Investors

Compare
1,829 Followers
Based on 793,704 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold VYNE
On average, investors allocate 0.00% of their portfolios to VYNE
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 793,704 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding VYNE

1.4%
Last 7
Days
9.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding VYNE, out of 793,704 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

VYNE Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of investors who made their portfolios public
The table shows changes in VYNE in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

VYNE Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Lucid Group
5.40%
-0.51%
-4.07%
7.34B
Consumer Cyclical
Nio
8.91%
-0.55%
-5.27%
8.67B
Consumer Cyclical
Marathon Digital Holdings
5.01%
-0.70%
-4.09%
4.72B
Financial
Block
3.61%
+0.58%
-1.21%
35.30B
Technology
Riot Platforms
4.57%
-0.56%
-5.84%
2.72B
Financial
Viking Therapeutics
3.84%
-0.74%
-7.54%
2.96B
Healthcare
Delta Air Lines
4.83%
+0.16%
-1.33%
29.81B
Industrials
Ford Motor
5.71%
-0.82%
-5.08%
40.82B
Consumer Cyclical
PDD Holdings
4.91%
-0.48%
-6.69%
172.71B
Consumer Cyclical
CVS Health
4.36%
-1.68%
-6.95%
84.73B
Healthcare
Based on the activity of 793,704 active portfolios
Open your Smart Portfolio

VYNE Investor Analysis

VYNE investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
14.1%
of VYNE holders
are under 35
Average Segment Performance
Average P/E Ratio18.15
Beta11.20
Dividend Yield3.92%
VYNE investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
60.7%
of VYNE holders
are between 35–55
Average Segment Performance
Average P/E Ratio15.89
Beta22.53
Dividend Yield3.38%
VYNE investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
25.2%
of VYNE holders
are over 55
Average Segment Performance
Average P/E Ratio13.53
Beta11.97
Dividend Yield3.63%
Overview of age group and performance of VYNE stock investors
See who invests in VYNE according to age group and performance.

FAQ

How many retail Investors hold VYNE?
<0.1% of TipRanks' retail investors hold VYNE in their portfolios.
    What is VYNE Investor Sentiment?
    VYNE’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of VYNE in the last 7 days?
      ▼ 1.4% of TipRanks' retail investors changed their holding of VYNE in the last 7 days.
        What percentage of retail investors changed their holding of VYNE in the last 30 days?
        ▼ 9.1% of TipRanks' retail investors changed their holding of VYNE in the last 30 days.
          What is the average age of retail investors who hold VYNE?
          The average age of VYNE Holders is between 35–55.
            What other stocks have VYNE investors also bought?
            VYNE Investors also bought LCID, NIO, MARA, XYZ, RIOT, VKTX, DAL, F, PDD, CVS.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALGNAlign Tech
              ALKSAlkermes
              AZNAstraZeneca
              CNCCentene
              CHRSCoherus Biosciences
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis